Avistone Pharmaceutical（Ningbo）Co., LTD.
1 clinical trials · Sponsor
◉ Watch Avistone Pharmaceutical（Ningbo）Co., LTD.
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of PLB1004 Combined With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation-positive (NCT07063329) | Avistone Pharmaceutical（Ningbo）Co., LTD. | 2025-08-08 |
Track Avistone Pharmaceutical（Ningbo）Co., LTD. automatically
Every clearance here is in the API, with alerts when new ones post.